| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10211915 | Clinical Lymphoma Myeloma and Leukemia | 2018 | 56 Pages |
Abstract
These results from an integrated analysis support a favorable benefit/risk profile of ibrutinib in patients with CLL/SLL and MCL.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Susan O'Brien, Peter Hillmen, Steven Coutre, Paul M. Barr, Graeme Fraser, Alessandra Tedeschi, Jan A. Burger, Marie-Sarah Dilhuydy, Georg Hess, Carol Moreno, Paula Cramer, Emily Liu, Stephen Chang, Jessica Vermeulen, Lori Styles, Angela Howes,